The purpose of this study was to evaluate the impact of extreme prematurity(<29 weeks gestation) on academic and neurodevelopmental outcomes. Our cohort (N=194) consisted of ELBW preterm infants (Mean BW 857g+162) born at one regional center between 1983-86 and enrolled in surfactant or maternal Betamethasone clinical trials. 153 infants (79%) survived, 4.5 y follow-up occurred in 149 (97%) and 123 (81%) were followed at ages 8-10 y. Control (C) infants were matched to each case based on birth date, mother's zip code, and health insurance at birth. Assessors (blinded to neonatal course) used the Woodcock-Johnson Psychoeducational Battery (WJ), Vineland Adaptive Behavior Scales (VABS, Mean 100±15), Parents and Teachers Connors Questionnaire(CQ) for attention (ADHD) and behavior. School age outcomes were classified as WJ scores less than 80 (Mean 100±15) for Reading (Read), Math and Spelling (Spell), Daily Living Score (DLS) <85 on VABS and CQ ADHD >2SD.Table
22.8% ELBW and 4.9% C required special education, 37.4% ELBW and 15.6% C had repeated a grade. Our experience demonstrates that children with ELBW in middle school years have a range of strengths and challenges. Inability to make some academic progress was rare. Supported by March of Dimes, ONY Inc., and Forest Laboratories.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Msall, M., Buck, G., Rogers, B. et al. 8 YEAR NEURODEVELOPMENTAL AND EDUCATIONAL OUTCOME OF EXTREMELY LOW BIRTH WEIGHT (ELBW) CHILDREN IN PROPHYLACTIC SURFACTANT OR MATERNAL BETAMETHASONE CLINICAL TRIALS. † 1623. Pediatr Res 39 (Suppl 4), 273 (1996). https://doi.org/10.1203/00006450-199604001-01646
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-01646